Inactive Instrument

Other languages Radius Health, Inc.

Equities

RDUS

US7504692077

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

EffRx Pharmaceuticals Signs Exclusive Licensing and Distribution Agreement with Radius Health, Inc for Binosto for the United States	23-09-19
Radius Health, Inc. Announces the Appointment of Al Medwar as Senior Vice President and Corporate Development	23-07-27
Radius Health, Inc. Appoints Erika Tooman as Senior Vice President/ General Counsel	23-04-06
Theramex Enters into an Exclusive Licensing Agreement with Radius Health Inc, to Commercialise ELADYNOS in the European Economic Area, United Kingdom, Australia and Brazil	23-03-20
Radius Health's Tymlos® (Abaloparatide) Receives U.S. FDA Approval as A Treatment to Increase Bone Density in Men with Osteoporosis At High Risk for Fracture	22-12-20
Radius Health, Inc. Announces Board Changes	22-08-15
Patient Square Capital, LP and Gurnet Point Capital Limited completed the acquisition of Radius Health, Inc. from Repertoire Partners LP, Velan Capital Investment Management LP and others.	22-08-09
Radius Health, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-09
Radius Health, Inc. and Teijin Pharma Limited Enter into an Amendment to License and Development Agreement	22-08-02
Velan-Repertoire to Withdraw Director Nominations due to Pending Sale of Radius Health	22-07-11
Radius Health Inc Issues an Investor Presentation to Shareholders	22-07-08
Radius Health Says First Patient Randomized in Trial of Prader-Willi Syndrome Symptoms	22-07-07
Radius Health, Inc. Announces First Patient Randomized in the Rad011 Pivotal Trial for Prader-Willi Syndrome	22-07-07
Radius Health, Inc Provides Information to the Shareholders	22-06-27
Velan Capital Investment Comments on Proposed Sale of Radius Health to Gurnet Point Capital and Patient Square Capital	22-06-24
Sector Update: Health Care Stocks Lead Thursday Markets Recovery	22-06-23
Sector Update: Health Care	22-06-23
Radius Health to Go Private in $890 Million Acquisition Deal With Gurnet Point Capital, Patient Square Capital	22-06-23
Radius Health to be Acquired by Gurnet Point Capital, Patient Square Capital in $890 Million Deal; Shares Rise	22-06-23
Menarini Group and Radius Health Submit New Drug Application to the U.S. FDA for Elacestrant	22-06-22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Radius Health, Inc.

Equities

RDUS

US7504692077

Other languages

Filters